drugset / Trial / NCT01850277

Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study

NCT01850277

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this prospective randomized study is to determine whether patients on cardiac resynchronization therapy with concomitant long-standing persistent or permanent atrial fibrillation would benefit from a strategy to restore and maintain sinus rhythm (rhythm control strategy) in comparison to a rate control strategy in terms of higher biventricular paced beats percentage.

Timeline

Start
2013-10
Primary completion
2016-12
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiodarone Small molecule 200 mg Oral